cystic fibrosis

January 14, 2021January 14, 2021

UK Rare Diseases Framework Opens to Improve Diagnosis, Access to Care

cystic fibrosis, News

U.K. Rare Diseases Framework, a government-led approach to raising national awareness of rare disorders, accelerating diagnoses, and improving patient care and treatment, is now in practice. This framework, signed ... Read more

January 12, 2021January 12, 2021

Phase 1/2 Trial to Test Phage Therapy for Chronic P. aeruginosa Infections

cystic fibrosis, News

A Phase 1/2 clinical trial, called CYPHY, to evaluate the phage therapy YPT-01 in treating chronic Pseudomonas aeruginosa infections in people with cystic fibrosis (CF) has been initiated at ... Read more

January 11, 2021January 11, 2021

CF Foundation Hosts COVID-19 Vaccine Panel Talk, Q&A on Thursday

cystic fibrosis, News

The Cystic Fibrosis Foundation (CFF) encourages cystic fibrosis (CF) patients to speak to their healthcare team about COVID-19 vaccines, in agreement with recommendations from the U.S. Centers for Disease Control ... Read more

January 8, 2021January 8, 2021

Study Examines Effects of Socioeconomics on Health of Youngsters

cystic fibrosis, News

Children with cystic fibrosis (CF) who live in more socioeconomically disadvantaged areas of the U.S. tend to have worse lung function and health outcomes than their counterparts in more ... Read more

January 7, 2021January 7, 2021

Inhaled-IV Antibiotic Combo May Better Treat Acute Flares Than IV-only Mix

cystic fibrosis, News

When given alongside the antibiotic Colistin (colistimethate), Cayston (aztreonam lysine), an inhaled antibiotic specifically targeting Pseudomonas aeruginosa, was superior to standard intravenous antibiotics at improving lung function and life quality ... Read more

January 5, 2021January 5, 2021

Health Canada Giving Priority Review to Trikafta

cystic fibrosis, News

Health Canada is reviewing an application that seeks the approval of Trikafta, a triple combination reported to treat 90% of all with cystic fibrosis (CF), or those with least one F508del ... Read more

January 4, 2021January 4, 2021

Arcturus to Develop ARCT-032 as RNA Therapy for CF

cystic fibrosis, News

Arcturus Therapeutics has selected ARCT-032, an aerosolized RNA-based therapy, to be developed as a novel therapeutic candidate for cystic fibrosis (CF). The therapy will use the company’s LUNAR delivery ... Read more

December 29, 2020January 4, 2021

FDA Expands Labels for 3 Vertex CFTR Modulators

cystic fibrosis, News

The U.S. Food and Drug Administration (FDA) has expanded the number of cystic fibrosis (CF)-related mutations considered responsive to and therefore eligible for Vertex Pharmaceuticals‘ three approved therapies. With these ... Read more

December 22, 2020December 22, 2020

Antibiotic Gentamicin Can Be Effective Without Causing Deafness, Study Finds

cystic fibrosis, News

Scientists discovered the subtypes of gentamicin — a broad-spectrum antibiotic often used to treat bacterial infections in people with cystic fibrosis (CF) — that are more likely to cause ... Read more